Carneiro-Filho, B.A., Lima, I.P.F., Araujo, D.H., Cavalcante, M.C., Carvalho, G.H.P., Brito, G.A.C., Lima, V., Montiero, S.M.N., Santos, F.N., Ribiero, R.A., Lima, A.A.M
L., & Brown, J
Currently, NICE guidance (NG71) for Parkinson's disease does not recommend GLP-1 receptor agonists for treating this condition
For example, excessive amounts of Vitamin D can lead to Vitamin D toxicity
Lipid Selection and Matrix Composition: High-purity phosphatidylcholine from non-GMO sunflower sources serves as the essential backbone of the phospholipid matrix, ensuring stable membrane fluidity and high encapsulation efficiency
Both medications have FDA-approved uses, though approval specifics vary depending on the product and intended use